Laugaard Lorenzen Ebbe, Christian Rehammar Jens, Jensen Maj-Britt, Ewertz Marianne, Brink Carsten
Laboratory of Radiation Physics, Department of Oncology, Odense University Hospital, Denmark.
Department of Plastic Surgery, Odense University Hospital, Denmark.
Radiother Oncol. 2020 Nov;152:103-110. doi: 10.1016/j.radonc.2020.08.007. Epub 2020 Aug 25.
The increase in the risk of heart disease from incidental exposure of the heart during radiotherapy for breast cancer has been estimated previously from retrospective data in Danish and Swedish women. Here we present an analysis of the Danish material updated with new cases and controls, extended follow-up period, and with refined dose estimates using simulator films or CT data.
From the database of the Danish Breast Cancer Cooperative Group, we identified 531 women diagnosed with early-stage breast cancer from 1977 to 2005, who developed subsequent ischemic heart disease (cases) and matched them to 1069 controls without heart disease after radiotherapy. Data were available for precise dose estimation for 196 cases and 413 controls receiving tangential photon techniques.
The median of the mean heart doses for the women receiving tangential radiotherapy was 2.41 Gy for left- and 0.68 Gy for right-sided radiotherapy. The mean heart dose was higher for cases than controls (0.84 Gy and 0.71 Gy, respectively; p < 0.001). In this group, the linear increase in the excess odds ratio of major coronary events per gray of mean heart dose (K) was 19 percent (95% Confidence Interval(CI) 1% to 63%, p = 0.02). For patients treated with electron techniques, there was no significant association between mean heart dose and the risk of major coronary events (K = -0.05, 95% CI -12% to 9%, p = 1.00).
The increase in the excess odds of major coronary events per gray mean heart dose using individual dose estimates is higher than previously reported.
此前已根据丹麦和瑞典女性的回顾性数据估算了乳腺癌放疗期间心脏意外受照导致心脏病风险的增加情况。在此,我们展示了对丹麦数据资料的分析,该分析纳入了新的病例与对照、延长了随访期,并使用模拟影像或CT数据对剂量估算进行了优化。
从丹麦乳腺癌协作组的数据库中,我们识别出1977年至2005年期间被诊断为早期乳腺癌且随后发生缺血性心脏病的531名女性(病例组),并将她们与1069名放疗后无心脏病的对照进行匹配。对于接受切线光子技术治疗的196例病例和413名对照,可获得精确的剂量估算数据。
接受切线放疗的女性,左侧心脏平均剂量的中位数为2.41 Gy,右侧为0.68 Gy。病例组的平均心脏剂量高于对照组(分别为0.84 Gy和0.71 Gy;p < 0.001)。在该组中,平均心脏剂量每增加1 Gy,主要冠状动脉事件的超额比值比(K)呈线性增加,增幅为19%(95%置信区间[CI]为1%至63%,p = 0.02)。对于接受电子技术治疗的患者,平均心脏剂量与主要冠状动脉事件风险之间无显著关联(K = -0.05,95% CI为-12%至9%,p = 1.00)。
使用个体剂量估算时,平均心脏剂量每增加1 Gy,主要冠状动脉事件的超额比值比增幅高于先前报道。